Gilead Sciences

YTD

ALL

Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About GILD

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.

CEO

Daniel P. O'Day

CEODaniel P. O'Day

Employees

17,600

Employees17,600

Headquarters

Foster City, California

HeadquartersFoster City, California

Founded

1987

Founded1987

Employees

17,600

Employees17,600

GILD Key Statistics

Market cap

135.13B

Market cap135.13B

Price-Earnings ratio

22.81

Price-Earnings ratio22.81

Dividend yield

2.86%

Dividend yield2.86%

Average volume

9.02M

Average volume9.02M

High today

$110.16

High today$110.16

Low today

$107.43

Low today$107.43

Open price

$108.92

Open price$108.92

Volume

23.27M

Volume23.27M

52 Week high

$119.96

52 Week high$119.96

52 Week low

$66.01

52 Week low$66.01

GILD News

Sherwood News 4d

Gilead wins approval for twice yearly HIV prevention shot

A syringe and some pills are in front of the logo of Gilead pharmaceutical company. (Photo by Nikos Pekiaridis/NurPhoto via Getty Images) Gilead won approval f...

Analyst ratings

60%

of 30 ratings

Buy

60%

Hold

40%

Sell

People also own

Based on the portfolios of people who own GILD. This list is generated using Robinhood data, and it’s not a recommendation.